Drugs / canola oil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01736202 Comparator | Mar 2012 → Jan 2022 | — | German Diabetes Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | canola oil | “Oral ingestion of palm oil or canola oil or water at timepoint zero” NCT01736202 ↗ |
| Route | Oral | “Oral ingestion of palm oil or canola oil or water at timepoint zero” NCT01736202 ↗ |